![]() | Name | Last modified | Size | Description |
---|---|---|---|---|
![]() | Parent Directory | - | ||
![]() | 05-contraindications-psilocybin.html | 2023-10-12 17:43 | 4.5K | |
![]() | 05-contraindications-ketamine.html | 2023-10-12 17:43 | 4.5K | |
![]() | 05-contraindications-mdma.html | 2023-10-12 17:43 | 4.5K | |
![]() | 05-contraindications.html | 2023-07-13 16:08 | 4.5K | |
![]() | 03-therapeutic-stance.html | 2023-10-12 17:43 | 4.7K | |
![]() | 02-numi-care-model.html | 2023-10-12 17:43 | 4.8K | |
![]() | 06-conclusion-2.html | 2023-10-12 17:43 | 6.4K | |
![]() | 01-introduction-2.html | 2023-10-12 17:43 | 6.5K | |
![]() | 04-effects-mdma.html | 2023-10-12 17:43 | 7.2K | |
![]() | 04-effects-ketamine.html | 2023-10-12 17:43 | 7.2K | |
![]() | 04-effects-psilocybin.html | 2023-10-12 17:43 | 7.2K | |
![]() | 04-effects.html | 2023-07-13 16:08 | 7.2K | |